Pfizer will launch a large study to test its COVID-19 vaccine for children below 12.
The company said on Tuesday that it has selected a dosing regime for the trial, in which 4,500 children will be enrolled at more than 90 clinical sites in the US, Finland, Poland and Spain.
Pfizer’s vaccine has been authorized for use in children from the age of 12 in Europe, the US and Canada.
A dose of 10 micrograms will be used in the trial among children between 5 and 12 years of age, and 3 micrograms among the age-group of 6 months to five years.
Umerkote: Elections officials on Friday conducted checks in the helicopter, carrying BJD leader and 5T…
Dhenkanal: Passengers of a private bus en route to Bhubaneswar from Talcher had a close…
Balasore: Three weeks after quitting BJD, sitting MLA from Soro Parshuram Dhada joined to BJP…
New Delhi: Remember Fardeen Khan, son of the late Feroz Khan? Fourteen years after Dulha…
Sambalpur: A native of Dalkibahal village under Gobindpur police limits in Odisha’s Sambalpur district recently…
Bhubaneswar: Amid the prevailing heatwave conditions, thunderstorm with lightning and light to moderate rain may…
New Delhi: The Central Bureau of Investigation (CBI) seized arms and ammunition, including foreign-made pistols,…
Bhubaneswar: Odisha will continue to reel under intense heatwave conditions till April 30, the India…